Another infliximab switching trial started

posted 02/10/2015

In The Netherlands another study has been initiated into the effects of switching patients form originator infliximab to biosimilar infliximab.

Biosimilar epoetin-α as effective as originator... Biosimilars/Research | Posted 02/10/2015
Formulation differences between generics and re... Generics/Research | Posted 02/10/2015
Biosimilar etanercept safe and effective Biosimilars/Research | Posted 02/10/2015
Pay-for-delay bill reintroduced Policies & Legislation | Posted 02/10/2015
FDA approval for guaifenesin generics Generics/News | Posted 02/10/2015
Stakeholder perceptions of generics Generics/Research | Posted 25/09/2015
FDA defends lack of biosimilars guidelines Guidelines | Posted 25/09/2015
Positive phase III results for bevacizumab bios... Biosimilars/Research | Posted 25/09/2015
Pfizer loses UK patent protection for Lyrica in... Policies & Legislation | Posted 25/09/2015
Biosimilar production in Malaysia Biosimilars/News | Posted 25/09/2015
Dutch medicines agency aims to clarify biosimil... Biosimilars/General | Posted 25/09/2015
The history of generics in France Generics/Research | Posted 19/09/2015
Concerns raised over CMS biosimilars reimbursem... Policies & Legislation | Posted 19/09/2015
Biosimilar insulin launched in the UK Biosimilars/News | Posted 18/09/2015
Patient adherence and generics Generics/Research | Posted 18/09/2015
Pharmacoeconomic modelling of biosimilars in th... Biosimilars/Research | Posted 18/09/2015
Biosimilars applications under review by EMA –... Biosimilars/General | Posted 18/09/2015
Mylan sued over generic prostate cancer drug Generics/News | Posted 18/09/2015
Comments on FDA’s guidance on naming biologicals Biosimilars/General | Posted 11/09/2015
Biosimilar etanercept approved in South Korea Biosimilars/News | Posted 11/09/2015
Observational study shows switching to generic... Generics/Research | Posted 11/09/2015
Etanar as effective as adalimumab and inflixima... Biosimilars/Research | Posted 11/09/2015
Yasmin generic launched in US Generics/News | Posted 11/09/2015
UCB sells generics unit to Lannett Pharma News | Posted 11/09/2015
Sun Pharma recalls drugs from troubled Halol plant Generics/General | Posted 11/09/2015
FDA issues draft guidance on naming biologicals Guidelines | Posted 04/09/2015
Zarxio first biosimilar to be launched in US Biosimilars/News | Posted 04/09/2015
Safety of generic immunosuppressants in solid o... Generics/Research | Posted 04/09/2015
US FTC clears Pfizer’s purchase of Hospira Pharma News | Posted 04/09/2015
Generics applications under review by EMA – Aug... Generics/General | Posted 04/09/2015
Phase III results of adalimumab biosimilar demo... Biosimilars/Research | Posted 04/09/2015
US FDA approval for Hep B and osteoporosis gene... Generics/News | Posted 04/09/2015
Generic imatinib non-inferior to Gleevec Generics/Research | Posted 28/08/2015
FDA issues warning letters to Indian firms Policies & Legislation | Posted 28/08/2015
Non-originator bevacizumab candidate non-inferi... Biosimilars/Research | Posted 28/08/2015
Rituximab similar biologic launched in India Biosimilars/News | Posted 28/08/2015
Alzheimer generic launched in the US Generics/News | Posted 28/08/2015
Australian approval for infliximab biosimilar Biosimilars/General | Posted 21/08/2015

Generics News Research General


Biosimilars News Research General